Wayne V. Moore

4.2k total citations
88 papers, 2.6k citations indexed

About

Wayne V. Moore is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Wayne V. Moore has authored 88 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Endocrinology, Diabetes and Metabolism, 27 papers in Surgery and 22 papers in Molecular Biology. Recurrent topics in Wayne V. Moore's work include Growth Hormone and Insulin-like Growth Factors (29 papers), Pancreatic function and diabetes (24 papers) and Diabetes and associated disorders (11 papers). Wayne V. Moore is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (29 papers), Pancreatic function and diabetes (24 papers) and Diabetes and associated disorders (11 papers). Wayne V. Moore collaborates with scholars based in United States, Switzerland and Australia. Wayne V. Moore's co-authors include J. Wolff, Paula S. Leppert, Karen Kover, David Donaldson, Pei Tong, Thomas Wiegmann, Arnold M. Chonko, Lisa Stehno‐Bittel, Barry W. Festoff and S. Janette Williams and has published in prestigious journals such as JAMA, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Wayne V. Moore

86 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wayne V. Moore United States 30 1.1k 923 908 600 250 88 2.6k
S Tarui Japan 31 867 0.8× 756 0.8× 506 0.6× 929 1.5× 415 1.7× 126 3.4k
Daniel L. Metzger Canada 29 736 0.7× 649 0.7× 621 0.7× 427 0.7× 187 0.7× 82 2.5k
Shinji Kosugi Japan 36 1.5k 1.3× 1.6k 1.7× 613 0.7× 346 0.6× 249 1.0× 177 4.4k
K. Berg Norway 32 869 0.8× 847 0.9× 438 0.5× 930 1.6× 909 3.6× 127 3.0k
José L. San Millán Spain 32 859 0.8× 1.7k 1.8× 1.6k 1.8× 263 0.4× 680 2.7× 45 5.5k
IONE A. KOURIDES United States 37 2.7k 2.4× 824 0.9× 535 0.6× 500 0.8× 124 0.5× 78 4.1k
Serap Turan Türkiye 31 861 0.8× 1.0k 1.1× 907 1.0× 409 0.7× 75 0.3× 140 2.8k
Wölfram Karges Germany 33 1.2k 1.1× 551 0.6× 970 1.1× 862 1.4× 109 0.4× 104 3.3k
George Koukoulis Greece 35 577 0.5× 684 0.7× 216 0.2× 932 1.6× 164 0.7× 134 3.5k
Jacky M. Burrin United Kingdom 30 992 0.9× 580 0.6× 426 0.5× 383 0.6× 101 0.4× 93 2.6k

Countries citing papers authored by Wayne V. Moore

Since Specialization
Citations

This map shows the geographic impact of Wayne V. Moore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wayne V. Moore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wayne V. Moore more than expected).

Fields of papers citing papers by Wayne V. Moore

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wayne V. Moore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wayne V. Moore. The network helps show where Wayne V. Moore may publish in the future.

Co-authorship network of co-authors of Wayne V. Moore

This figure shows the co-authorship network connecting the top 25 collaborators of Wayne V. Moore. A scholar is included among the top collaborators of Wayne V. Moore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wayne V. Moore. Wayne V. Moore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gitelman, Stephen E., Peter A. Gottlieb, Eric I. Felner, et al.. (2016). Antithymocyte globulin therapy for patients with recent-onset type 1 diabetes: 2 year results of a randomised trial. Diabetologia. 59(6). 1153–1161. 65 indexed citations
2.
Moore, Wayne V., Gad B. Kletter, Bradley S. Miller, et al.. (2015). A Randomized Safety and Efficacy Study of Somavaratan (VRS-317), a Long-Acting rhGH, in Pediatric Growth Hormone Deficiency. The Journal of Clinical Endocrinology & Metabolism. 101(3). 1091–1097. 29 indexed citations
3.
Kover, Karen, Pei Tong, Dara Watkins, et al.. (2013). Expression and Regulation of Nampt in Human Islets. PLoS ONE. 8(3). e58767–e58767. 43 indexed citations
4.
Ugrasbul, Figen, Wayne V. Moore, Pei Tong, & Karen Kover. (2008). Prevention of diabetes: effect of mycophenolate mofetil and anti-CD25 on onset of diabetes in the DRBB rat. Pediatric Diabetes. 9(6). 596–601. 14 indexed citations
5.
Alon, Uri S., et al.. (2008). Calcimimetics as an Adjuvant Treatment for Familial Hypophosphatemic Rickets. Clinical Journal of the American Society of Nephrology. 3(3). 658–664. 104 indexed citations
6.
Moore, Wayne V., et al.. (2005). Bone Density After Completion of Growth Hormone Treatment for Growth Failure. Journal of Pediatric Endocrinology and Metabolism. 18(11). 1053–61. 1 indexed citations
7.
Jacobson, Jill D., et al.. (2004). Use of aromatase inhibitors in children with short stature.. PubMed. 2(1). 2–7. 6 indexed citations
8.
Kover, Karen, et al.. (2001). CD40/154 blockade and rejection of islet allografts in the streptozotocin and autoimmune diabetic rat. Pediatric Diabetes. 2(4). 178–183. 8 indexed citations
9.
Moore, Wayne V.. (1997). Growth hormone therapy for non-growth hormone deficient short stature. Current Opinion in Endocrinology & Diabetes. 4(2). 108–114.
10.
Ketchum, Robert J., et al.. (1995). INTRATHYMIC TRANSPLANTATION OF ALLOGENEIC PERINATAL ISLETS DOES NOT INDUCE DONOR-SPECIFIC TOLERANCE. Transplantation. 59(5). 784–787. 2 indexed citations
11.
Horton, William A., et al.. (1992). Growth hormone therapy in achondroplasia. American Journal of Medical Genetics. 42(5). 667–670. 36 indexed citations
12.
Moore, Wayne V., et al.. (1991). Comparison of Overnight Serum Human Growth Hormone (hGH) Secretory Profiles Measured by Three Different Methods. Journal of Pediatric Endocrinology and Metabolism. 4(3). 2 indexed citations
13.
Donaldson, David, et al.. (1991). Reliability of Stimulated and Spontaneous Growth Hormone (GH) Levels for Identifying the Child with Low GH Secretion*. The Journal of Clinical Endocrinology & Metabolism. 72(3). 647–652. 30 indexed citations
14.
Stevenson, J.L., et al.. (1990). Correlation of Urinary Albumin andβ-2-Microglobulin and Growth Hormone Excretion in Patients with Diabetes Mellitus and Short Stature*. The Journal of Clinical Endocrinology & Metabolism. 71(3). 611–617. 7 indexed citations
15.
Rosenfeld, Ron G., Raymond L. Hintz, Ann J. Johanson, et al.. (1988). Three-year results of a randomized prospective trial of methionyl human growth hormone and oxandrolone in Turner syndrome. The Journal of Pediatrics. 113(2). 393–400. 91 indexed citations
16.
Moore, Wayne V.. (1988). Anabolic Steroid Use in Adolescence. JAMA. 260(23). 3484–3484. 24 indexed citations
17.
18.
Leppert, Paula S., et al.. (1981). IN VIVO EFFECT OF HUMAN GROWTH HORMONE ON HEPATIC ADENYLATE CYCLASE ACTIVITY. Endocrinology. 109(3). 990–992. 9 indexed citations
19.
Rawitch, Allen B., Wayne V. Moore, & Edward H. Frieden. (1980). Relaxin-insulin homology: Predictions of secondary structure and lack of competitive binding. International Journal of Biochemistry. 11(5). 357–362. 12 indexed citations
20.
Moore, Wayne V. & J. Wolff. (1973). Binding of Prostaglandin E1 to Beef Thyroid Membranes. Journal of Biological Chemistry. 248(16). 5705–5711. 96 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by S Tarui Breakdown of academic impact, for papers by Daniel L. Metzger Breakdown of academic impact, for papers by Shinji Kosugi Breakdown of academic impact, for papers by K. Berg Breakdown of academic impact, for papers by José L. San Millán Breakdown of academic impact, for papers by IONE A. KOURIDES Breakdown of academic impact, for papers by Serap Turan Breakdown of academic impact, for papers by Wölfram Karges Breakdown of academic impact, for papers by George Koukoulis Breakdown of academic impact, for papers by Jacky M. Burrin
Rankless by CCL
2026